GlassScriptGeneral - Non-Vascular Intervention
Payments companies reported to CMS as associated with General - Non-Vascular Intervention. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with General - Non-Vascular Intervention, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with General - Non-Vascular Intervention
These are the largest totals companies reported as associated with General - Non-Vascular Intervention. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gary Breitbart | South Plainfield, NJ | Vascular Surgery | $269.82 |
| Christopher Cappellini | Edison, NJ | Vascular Surgery | $269.82 |
| Geoffrey Wong | South Plainfield, NJ | Vascular Surgery | $139.35 |
| Neil Poulsen | Rockaway, NJ | Vascular Surgery | $138.28 |
| Hunaiz Patel | South Plainfield, NJ | Vascular Surgery | $130.47 |
| Raymond Holmes | Clifton, NJ | Vascular Surgery | $128.29 |
| Michael Addis | Springfield, NJ | Vascular Surgery | $128.29 |
| Mallika Gopal | New York, NY | Vascular Surgery | $128.28 |
| Bruce Brener | Livingston, NJ | Vascular Surgery | $128.28 |
| Michael Curi | Newark, NJ | Vascular Surgery | $128.28 |
Prescribed General - Non-Vascular Intervention?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.